Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 355.00
-5.00 (-1.39%)
Sep 11, 2026, 3:30 PM IST
NSE:INDRAMEDCO Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,836 | 1,610 | 1,240 | 861.5 | 586.2 |
Depreciation & Amortization | 431.3 | 438.7 | 394.6 | 378.4 | 332.7 |
Other Amortization | 5 | 4.6 | 6.2 | 14.3 | 16.7 |
Loss (Gain) From Sale of Assets | 5.3 | 5.2 | 11.7 | 8.7 | 57.7 |
Loss (Gain) From Sale of Investments | -11.4 | - | - | - | - |
Other Operating Activities | -292.1 | -252.9 | -205.2 | 115.2 | -15.8 |
Change in Accounts Receivable | -319.1 | -193.6 | 138.7 | -234.9 | 259.5 |
Change in Inventory | -8.7 | 5.4 | 9.2 | 15.4 | -12.5 |
Change in Accounts Payable | 27.9 | -49.8 | 406.7 | 286.1 | -281.5 |
Operating Cash Flow | 1,674 | 1,568 | 2,002 | 1,445 | 943 |
Operating Cash Flow Growth | 6.82% | -21.68% | 38.54% | 53.20% | 251.73% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -596.5 | -363.3 | -693.9 | -445.8 | -294.8 |
Investment in Securities | 11.4 | - | - | - | - |
Other Investing Activities | -1,191 | -746.6 | -890.4 | -633.3 | -446.3 |
Investing Cash Flow | -1,776 | -1,110 | -1,584 | -1,079 | -741.1 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -24.3 | -21.3 | -37.9 | -28.3 | -25.1 |
Lease Payments | -24.3 | -21.3 | -37.9 | -28.3 | -25.1 |
Total Debt Repaid | -24.3 | -21.3 | -37.9 | -28.3 | -25.1 |
Net Debt Issued (Repaid) | -24.3 | -21.3 | -37.9 | -28.3 | -25.1 |
Common Dividends Paid | -410.3 | -407.3 | -275.4 | -228.4 | -2.6 |
Other Financing Activities | -29.2 | -30.2 | -10.5 | -3.7 | -6 |
Financing Cash Flow | -463.8 | -458.8 | -323.8 | -260.4 | -33.7 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -565.5 | -1.2 | 93.4 | 105.2 | 168.2 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,078 | 1,204 | 1,308 | 998.9 | 648.2 |
Free Cash Flow Growth | -10.49% | -7.91% | 30.90% | 54.10% | 1008.03% |
Free Cash Flow Margin | 7.27% | 8.88% | 10.51% | 9.09% | 7.30% |
Free Cash Flow Per Share | 11.76 | 13.14 | 14.26 | 10.90 | 7.07 |
Levered Free Cash Flow | 673.36 | 1,177 | 1,139 | 956.2 | 606.55 |
Unlevered Free Cash Flow | 691.68 | 1,196 | 1,146 | 959.08 | 610.36 |
Free Cash Flow After Leases | 1,054 | 1,183 | 1,270 | 970.6 | 623.1 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 29.3 | 30.3 | 10.6 | 4.6 | 6.1 |
Cash Income Tax Paid | 669.2 | 609.8 | 468.3 | 98.5 | 195.1 |
Change in Working Capital | -299.9 | -238 | 554.6 | 66.6 | -34.5 |